Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.
暂无分享,去创建一个
A. Mammen | N. Lechtzin | S. Danoff | SeungHye Han | L. Casciola-Rosen | L. Christopher‐Stine | J. Oaks | C. Johnson | A. Truong | G. Connors | S. Han | B. Richardson | A. Mammen | L. Casciola‐Rosen | C. Johnson | S. K. Danoff
[1] Ami A. Shah,et al. Race and Association With Disease Manifestations and Mortality in Scleroderma , 2013, Medicine.
[2] M. Rice,et al. The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies , 2013, Medicine.
[3] O. Benveniste,et al. Clinical Heterogeneity and Outcomes of Antisynthetase Syndrome , 2013, Current Rheumatology Reports.
[4] Nigel J Walker,et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. , 2012, Arthritis and rheumatism.
[5] C. Oddis,et al. Pulmonary manifestations of the idiopathic inflammatory myopathies. , 2010, Clinics in chest medicine.
[6] N. Kaminski,et al. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. , 2009, Arthritis and rheumatism.
[7] P Bélisle,et al. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences , 2008, Annals of the rheumatic diseases.
[8] Jonathan G Goldin,et al. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. , 2008, Chest.
[9] L. Jorfeldt,et al. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. , 2008, Arthritis and rheumatism.
[10] K. Nishimura,et al. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period , 2008, Modern rheumatology.
[11] T. Nakazono,et al. High-resolution computed tomography characterization of interstitial lung diseases in polymyositis/dermatomyositis. , 2008, The Journal of rheumatology.
[12] Yue-ying Gu,et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study , 2007, Clinical Rheumatology.
[13] D. Chung,et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. , 2005, Rheumatology.
[14] G. Raghu,et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. , 2005, American journal of respiratory and critical care medicine.
[15] T. Mimori,et al. Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy. , 2004, The Journal of rheumatology.
[16] A. Nicholson,et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis , 2004, Histopathology.
[17] M. Hamidou,et al. Le syndrome des antisynthétases , 2003 .
[18] E. Hachulla,et al. Interstitial lung disease in polymyositis and dermatomyositis. , 2002, Arthritis and rheumatism.
[19] I. D. Johnston,et al. American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias , 2002 .
[20] D. Schroeder,et al. Polymyositis-dermatomyositis-associated interstitial lung disease. , 2001, American journal of respiratory and critical care medicine.
[21] Ò. Miró,et al. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement. , 1996, The Journal of rheumatology.
[22] N. Rothfield,et al. Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis. , 1996, Arthritis and rheumatism.
[23] M. Arakawa,et al. [Prognosis of interstitial pneumonitis (IP) in polymyositis (PM)/dermatomyositis (DM)]. , 1994, Ryumachi. [Rheumatism].
[24] J. Hughes,et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. , 1990, The Quarterly journal of medicine.
[25] E. Arsura,et al. Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. , 1988, Seminars in arthritis and rheumatism.
[26] F. Arnett,et al. The Jo-1 antibody system in myositis: relationships to clinical features and HLA. , 1981, The Journal of rheumatology.
[27] J. Hankinson,et al. SERIES ''ATS/ERS TASK FORCE: STANDARDISATION OF LUNG FUNCTION TESTING'' Edited by V. Brusasco, R. Crapo and G. Viegi Number 4 in this Series Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005 .
[28] P. Leissner,et al. Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county. , 1993, Neuroepidemiology.
[29] A. Bohan,et al. Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.
[30] A. Bohan,et al. Polymyositis and dermatomyositis (first of two parts). , 1975, The New England journal of medicine.